Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis
Medicare pricing data for 77 providers across 9 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS code 81249) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $587.66, but hospitals typically charge $661.47 — a 1.1x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $587.66, your out-of-pocket cost would be approximately $117.53. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $587.66 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Louisiana | $588 | $718 | 2 | 37 | +0.1% |
| Mississippi | $588 | $1,800 | 1 | 30 | +0.1% |
| Pennsylvania | $588 | $601 | 2 | 2,396 | +0.1% |
| Texas | $588 | $631 | 33 | 12,519 | +0.1% |
| Arizona | $588 | $700 | 1 | 23 | +0.1% |
| Colorado | $588 | $2,469 | 2 | 87 | +0.1% |
| Florida | $588 | $662 | 25 | 14,992 | +0.0% |
| Oklahoma | $587 | $878 | 3 | 210 | -0.1% |
| New Jersey | $586 | $709 | 7 | 5,915 | -0.3% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber